Kirk G. Nielsen

Kirk G. Nielsen (board member) discloses dealings in 3 companies, chiefly CVRx, Inc., Inari Medical, Inc. and SpyGlass Pharma, Inc. We count 15 filings; the first trade dates from 27 May 2021 and the latest from 1 June 2026.

On the market, this insider has only ever bought: 8 purchases, €650k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 share grants and 2 option exercises.

In size, the median ticket on the buying side is €53k. 2 out of 8 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

On 3 June 2026 came the latest disclosure, a share grant in CVRx, Inc. The most recent open-market purchase was published on 19 May 2025, 517 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.